#AcceleratingSafeAI. Background in market and AI product development for Market Primes, Private Equity & Government Investors. All comments are mine alone.
Fantastic Expert Forum event with the @LSWalesCDdCymru - "Artificial Intelligence for Wales, what next?"
Good to do a clinical Pros & Cons quickfire session on palliative care with @jacswork of @carefulai and @ucl
core banking is still so shit, i could go on, particularly for businesses and for funds
you can build a multi-$b business modernising all of it
just look at thought machine
press.airstreet.com/p/findin…
As the ex AI Innovation lead in the UK NHS, concentrating on behaviour change /mental health support, @AravSrinivas I can confirm that your Discover article is a Must Read. perplexity.ai/page/openai-an… maybe add some sector analysis
Behaviour change is instrumental for positive health outcomes. It is, arguably, the only sustainable method in any economy, yet very difficult to do safely and digitally. This is why the new @ariannahuff and @sama partnership is one to watch, as the response of the competition.
It's interesting how country or sector AI regulation /frameworks have little effect on the positive societal output of AI firms, but how AI enabled continuous multi-famework monitoring does. bit.ly/AutoDeclare
What industry wants is to "enter the medical device documentation and out comes the your certification".... Well evidencing compliance at a process and code level is enabled with AI i.e. carefulai.com/autodeclare.ht… the regulator needs to catch up @US_FDA@MHRAgovuk
In the race towards GenAI models. China appears to be moving to have lighter regulatory touch on models that do not affect the public. Interesting. I wonder how the US will respond.
For the TL:DR community. @BSI_UK@MHRAgovuk The complete medical device value chain may be affected by the good practice guidelines from IMDRF. So users, providers, developers and researchers need to respond to this @US_FDA hosted groups call for feedback.
Great event @responsibleaiuk. The presentation by @icabbs highlighting the balence between Care Navigation in the form of AI and Clinical Decision support, is a subject worthy of NHS planner's time, as are the themes arising
A question, @kevin_scott. Is the speed of valuable innovation only limited by AI's ability to openly create novelty, make it safe, and test it with AI that represents those who would buy it. If so who does this now?
🙏 last friday, we brought together 200 researchers, founders, builders, and friends together in central london for the eighth edition of @raais for a day of ai-first best practice, conversations, and positive-sum vibes.
a few of my reflections of the day: